Clinical Trial Update: In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing artemether/lumefantrine vs dihydroartemisinin-piperaquine for uncomplicated malaria and evaluating parasite genetics related to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Artemether-lumefantrine (artemether and lumefantrine)
• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: National Institute for Medical Research, Tanzania | Conditions: Malaria | Phase 4 | Status: COMPLETED